Artificial Pancreas Device Systems Market Size & Share 2023 to 2032
Market Size by Device Type (Threshold Suspend Device Systems, Control-to-range (CTR) Systems, Control-to-target (CTT) Systems), by End Use (Hospitals and Clinics, Homecare) – Global Forecast.
Report ID: GMI6912
|
Published Date: October 2023
|
Report Format: PDF
Download Free PDF
Authors:
Monali Tayade, Jignesh Rawal
Artificial Pancreas Device Systems Market Size
Artificial Pancreas Device Systems Market size was valued at USD 331 million in 2022 and is estimated to account for USD 757.5 million by 2032. Increasing number of people suffering from chronic conditions such as obesity resulting in occurrence of diabetes will act as a primary factor for driving market demand.
Artificial Pancreas Device Systems Market Key Takeaways
Market Size & Growth
Key Market Drivers
Challenges
For instance, according to official statistics, over 80% of people suffering from Type 2 diabetes are obese. An artificial pancreas device system (APDS) is a medical device designed for individuals with diabetes. It combines a continuous glucose monitor (CGM), the market of which is projected to reach USD 21.4 billion by 2032, an insulin pump, and a computer algorithm to automatically regulate blood glucose levels. The system continuously monitors glucose levels and adjusts insulin delivery in real-time, mimicking the function of healthy pancreas.
Factors such as sedentary lifestyle, unhealthy diet, and an aging population base contribute to the rising incidence of both type 1 and type 2 diabetes. For instance, as per the report of International Diabetes Federation's Diabetes Atlas 10th edition, the number of adults (aged 20-79) suffering from diabetes is anticipated to surge to 783.2 million by 2045. These statistics underscore the escalating worldwide burden of diabetes and its significant impact on public health. Therefore, there is an urgent need for effective and efficient methods to manage the disease. APDS offers a promising solution by automating glycemic control, helping patients maintain stable blood glucose levels. Furthermore, prominent medical device companies are heavily investing in APDS technology leading to the development of more advanced, user-friendly systems, improving performance, patient outcomes, and market adoption, ultimately driving market expansion.
COVID-19 Impact
The COVID-19 pandemic had a significant impact on the APDS market. Disruptions in supply chains, healthcare resource allocation, and economic uncertainties led to delays in APDS production and adoption. Additionally, clinical trials and research were also affected, while regulatory delays hindered market entry. Additionally, patient concerns about visiting healthcare facilities during the pandemic further reduced APDS utilization. Thus, these combined factors created a challenging environment for the APDS market, negatively impacting its growth and adoption during the pandemic.
Artificial Pancreas Device Systems Market Trends
Rising demand for automated glycemic control systems such as APDS, technological advancements in CGM sensors, and increase in investment towards research and development by key players is driving the market progress. Technological improvements have transformed CGM sensors into smaller, more accurate, and less invasive devices, greatly enhancing patient comfort and overall usability. This heightened accuracy ensures that APDS can make precise insulin dosing adjustments, resulting in improved glycemic control and a reduced risk of hypoglycemia and hyperglycemia. As these technological advancements expand the appeal of APDS to a broader user base and gain increased clinical endorsement.
Traditional diabetes management methods involve multiple daily injections or manual adjustments of insulin doses, that can be burdensome and challenging for patients to maintain consistently. Thus, the demand for automated systems such as APDS is increasing among diabetic patients. Moreover, as demand increases, medical device companies are focusing on developing more advanced solutions, which can be another factor in the high adoption of APDS. For instance, the Medtronic MiniMed 780G artificial pancreas system has received approval from the Food and Drug Administration (FDA) for use in individuals aged 7 and above. This system offers automatic adjustments and real-time corrections to blood sugar levels at 5-minute intervals, including correction doses, as part of its meal detection technology.
Artificial Pancreas Device Systems Market Analysis:
The market by device type is categorized into threshold suspend device systems, control-to-range (CTR) systems, control-to-target (CTT) systems. The threshold suspends device systems segment garnered USD 175 million revenue size in the year 2022. The dominance of the segment can be attributed to their advanced safety features.
Thus, the reduced hypoglycemic events and enhanced patient safety has been a key driver for market development.
Based on end-use, the artificial pancreas device systems market is segmented into hospitals and clinics, homecare, and others. The hospitals and clinics segment garnered USD 102 million revenue size in the year 2022.
Therefore, segments contributions create a conducive environment for APDS adoption and contribute significantly to the market size.
U.S. artificial pancreas device systems market accounted for USD 122 million revenue size in 2022 and is predicted to witness substantial market growth.
Artificial Pancreas Device Systems Market Share
The ADPS industry is consolidated in nature with major companies competing to offer superior APDS in this business space. Medtronic Plc, Johnson & Johnson Services Inc, Bigfoot Biomedical, Tandem Diabetes Care, Inc., Pancreum, Inc, etc. are some of the major players holding majority of share in this market. These companies are focusing their efforts on continuous product innovation in order to acquire substantial market share. For instance, Medtronic Plc is engaged in developing advanced artificial pancreas system. Other companies such as Johnson & Johnson Services Inc, Bigfoot Biomedical are focusing on bringing advanced products to the market to gain competitive advantage and expand their client base. The major strategies adopted by the company involves geographical expansion, new product launch, distribution agreements, etc.
Some of the eminent market participants operating in in the artificial pancreas device systems industry include:
Artificial Pancreas Device Systems Industry News:
Artificial pancreas device systems market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD and volume in Units from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
By Device Type, 2018-2032 (USD Million & Units)
By End-use, 2018-2032 (USD Million)
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →